# Phase 4 fibrosis trials recruiting: 22 (November 2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 22 trials in phase 4 for fibrosis that are recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Recruiting Phase 4 fibrosis trials: 22 rows for $5, recruiting or not yet recruiting on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 2 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/recruiting/phase-4/fibrosis

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 22
- Recruiting or not yet: 22
- Read on: November 19, 2026

## Trials

The 22 newest of 22, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| October 29, 2026 | NCT07903311 | Iron Repletion in Cystic Fibrosis | University of Michigan | Phase 4 | Not yet recruiting | Cystic Fibrosis, Iron Deficiencies, Iron Deficiency Diseases | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07903311) |
| October 6, 2026 | NCT07859839 | Gabapentin vs. Benzonatate vs. Standard of Care for Cough in ILD | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | Not yet recruiting | Interstitial Lung Disease | 177 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07859839) |
| September 15, 2026 | NCT07820995 | Mechanistic Evaluation of Atrasentan in Patients With IgA Nephropathy (IgAN) | University of Illinois Chicago | Phase 4 | Not yet recruiting | IgA Nephropathy (IgAN), Immunoglobulin A Nephropathy (IgAN) | 20 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07820995) |
| September 9, 2026 | NCT07809867 | Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor in Cystic Fibrosis | Istituto Giannina Gaslini | Phase 4 | Recruiting | Cystic Fibrosis (CF) | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07809867) |
| September 2, 2026 | NCT07800598 | Role of Allopurinol in Prevention of Complications Related to Decompensated Cirrhosis of Liver | Bangladesh Medical University | Phase 4 | Recruiting | Cirrhoses, Liver, Decompensated Cirrhosis of Liver | 54 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07800598) |
| May 6, 2026 | NCT07570888 | This is a Trial Designed to Evaluate the Combination of Nerandomilast With Mycophenolate Across a Wide Variety of Pulmonary Fibrosis... | University of British Columbia | Phase 4 | Not yet recruiting | Pulmonary Fibrosis, Interstitial Lung Disease (ILD) | 120 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07570888) |
| April 9, 2026 | NCT07521332 | Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis | Asian Institute Of Medical Sciences | Phase 4 | Recruiting | Cirrhosis, Esophageal and Gastric Varices, Ascites, Hepatic Encephalopathy, Portal Vein Thrombosis, Portal Hypertension | 220 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07521332) |
| February 12, 2026 | NCT07405944 | Vericiguat and Reverse Remodeling Indices in Heart Failure | University Medical Centre Ljubljana | Phase 4 | Recruiting | Heart Failure With Reduced Ejection Fraction (HFrEF), Chronic Heart Failure | 70 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405944) |
| January 8, 2026 | NCT07325357 | Effect of Pirfenidone on TA Fibrosis | Shanghai Zhongshan Hospital | Phase 4 | Not yet recruiting | Takayasu Arteritis | 92 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07325357) |
| January 7, 2026 | NCT07322237 | DICE Study- Diastolic Improvement With Carvedilol & Empagliflozin in Patients With Cirrhosis | Post Graduate Institute of Medical Education and Research, Chandigarh | Phase 4 | Recruiting | Cirrhotic Cardiomyopathy, Empagliflozin, Cardiometabolic Risk Factors, Cirrhosis | 400 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07322237) |
| August 29, 2025 | NCT07148739 | Ensuring Access to Optimal Therapy in CF: The ENACT Study | Arkansas Children's Hospital Research Institute | Phase 4 | Recruiting | Cystic Fibrosis (CF) | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07148739) |
| August 20, 2025 | NCT07132515 | Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC | Mansoura University | Phase 4 | Recruiting | Cirrhosis, HCC - Hepatocellular Carcinoma, Portal Vein Thrombosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07132515) |
| March 18, 2025 | NCT06881628 | Tranxemic Acid and Vitamin K Injection to Control Upper Gastrointestinal Bleeding in Cirrhotic Patients | Tanta University | Phase 4 | Recruiting | Upper Gastrointestinal Bleeding (UGIB), Variceal Bleeding, Cirrhosis | 194 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06881628) |
| February 5, 2025 | NCT06808074 | A Study to Evaluate Role of Inhaled Amikacin to Prevent Ventilator Associated Pneumonia in Patients With Cirrhosis | Asian Institute of Gastroenterology, India | Phase 4 | Recruiting | Hepatic Encephalopathy, Cirrhosis, Ventilator Associated Pneumonia (VAP) | 162 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06808074) |
| September 19, 2024 | NCT06594783 | Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders | Taipei Veterans General Hospital, Taiwan | Phase 4 | Recruiting | Cirrhosis, Esophageal Varices | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06594783) |
| September 1, 2023 | NCT06021860 | A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in... | CMP Development, LLC | Phase 4 | Not yet recruiting | Edema Due to Heart Failure or Cirrhosis | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06021860) |
| January 30, 2023 | NCT05704036 | Estrogen Supplementation and Bone Health in Women With CF | Johns Hopkins University | Phase 4 | Recruiting | Cystic Fibrosis, Hypoestrogenism | 75 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05704036) |
| September 21, 2022 | NCT05548283 | Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study | Sponsor not shown (see the record) | Phase 4 | Recruiting | Cystic Fibrosis, Cystic Fibrosis Pulmonary Exacerbation | 730 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05548283) |
| June 23, 2022 | NCT05428826 | Early Discontinuation of Steroid Treatment in Negative FDG-PET/CT Patients With Idiopathic Retroperitoneal Fibrosis | Assistance Publique - Hôpitaux de Paris | Phase 4 | Recruiting | Idiopathic Retroperitoneal Fibrosis | 41 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05428826) |
| October 19, 2020 | NCT04588077 | Comparison Between 2-dose Versus 3-dose Regimens of Heplisav B in Cirrhosis | Mercy Medical Center | Phase 4 | Recruiting | Hepatitis B, Cirrhosis, Liver, Chronic Liver Disease | 200 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04588077) |
| June 25, 2020 | NCT04448028 | Stop of Proton-pump Inhibitor Treatment in Patients With Liver Cirrhosis - a Double-blind, Placebo-controlled Trial | Universitätsklinikum Hamburg-Eppendorf | Phase 4 | Recruiting | Liver Cirrhosis | 476 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04448028) |
| April 19, 2019 | NCT03921060 | Markers of Osteoporosis in Cystic Fibrosis | University of Texas Southwestern Medical Center | Phase 4 | Recruiting | Cystic Fibrosis | 100 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT03921060) |

## Sponsors with the most

| Sponsor | Trials |
| --- | --- |
| Post Graduate Institute of Medical Education and Research, Chandigarh | 2 |
| Tanta University | 1 |
| Bangladesh Medical University | 1 |
| University of British Columbia | 1 |
| Mercy Medical Center | 1 |
| University Medical Centre Ljubljana | 1 |
| Asian Institute of Gastroenterology, India | 1 |
| Johns Hopkins University | 1 |
| Assistance Publique - Hôpitaux de Paris | 1 |
| University of Michigan | 1 |
| Arkansas Children's Hospital Research Institute | 1 |
| Istituto Giannina Gaslini | 1 |
| CMP Development, LLC | 1 |
| Taipei Veterans General Hospital, Taiwan | 1 |
| University of Illinois Chicago | 1 |
| Universitätsklinikum Hamburg-Eppendorf | 1 |
| Asian Institute Of Medical Sciences | 1 |
| University of Texas Southwestern Medical Center | 1 |
| Mansoura University | 1 |
| Shanghai Zhongshan Hospital | 1 |

## By country

| Country | Trials |
| --- | --- |
| United States | 7 |
| India | 3 |
| Egypt | 2 |
| Bangladesh | 1 |
| Canada | 1 |
| Slovenia | 1 |
| France | 1 |
| Italy | 1 |
| Taiwan | 1 |
| Germany | 1 |
| Pakistan | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Mediterranean restaurants in the United States](https://specstream.ai/data/businesses/mediterranean-restaurants/united-states)
- [Public adjusters in the United States](https://specstream.ai/data/businesses/public-adjusters/united-states)
- [Tractor dealers in the United States](https://specstream.ai/data/businesses/tractor-dealers/united-states)
- [B2B cleaning and waste management companies in the United States](https://specstream.ai/data/businesses/b2b-cleaning-and-waste-management-companies/united-states)
- [College counseling companies in the United States](https://specstream.ai/data/businesses/college-counseling-companies/united-states)
- [Financial advisory firms in the United States](https://specstream.ai/data/businesses/financial-advisory-firms/united-states)
